Form 8 (DD) - Novae Group plc FORM 8 (DD)

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
16
Form 8 (DD) - Novae Group plc

FORM 8 (DD)

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS) Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser: Reeken Patel
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):      The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named. N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:      Use a separate form for each offeror/offeree Novae Group plc
(d) Status of person making the disclosure:      e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree) Person acting in concert with the offeree (Novae Group plc)
(e) Date dealing undertaken: 28 September 2017
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?      If it is a cash offer or possible cash offer, state "N/A" YES / NO / N/A If YES, specify which:

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

Class of relevant security:    
    Interests Short positions
Number %A Number %
(1) Relevant securities owned and/or controlled: 96,291 0.14 Nil Nil
(2) Cash-settled derivatives:   Nil Nil Nil Nil
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: Nil Nil Nil Nil
       TOTAL: 96,291 0.14 Nil Nil

A. Percentage calculations are based on Novae Group plc's total number of ordinary shares in issue being    64,425,640.

  1. Interests held as options under Novae Group plc share plans following the dealing:
Class of Relevant Security: Ordinary Shares (under option) Share Plan Vesting Date Exercise Price (per share)
         

[A] The vesting of the award is conditional on continued employment and subject to other rules of the plan. [B]The vesting of the award is subject to continued employment and performance conditions.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(c)        Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists: N/A
Details, including nature of the rights concerned and relevant percentages: N/A

3.         DEALINGS BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

(i)         Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

Class of relevant security Purchase/sale   Number of securities Price per unit
       

(ii)        Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

Class of relevant security Purchases/ sales   Total number of securities Highest price per unit paid/received Lowest price per unit paid/received
           

(b)        Cash-settled derivative transactions

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit
           

(c)        Stock-settled derivative transactions (including options)

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii)        Exercise

Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit
           

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
Ordinary Shares Vesting Vesting of 77,340 shares awarded under the Deferred Bonus Plan  
Ordinary Shares Vesting Vesting of 16,554 shares awarded under the 2007 Long Term Incentive Plan  

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person: Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"
None  

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
None    

(c)        Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions) YES/NO
Supplemental Form 8 (SBL) YES/NO
Date of disclosure: 28 September 2017
Contact name: Alexandra Moon
Telephone number: +44 (0) 20 7050 9000

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

China Automotive Systems Hits Milestone with ASPICE 4.0 CL2

Updated Category News Views 16

An Automotive Feat in R&D Now here's a story that should make waves across the automotive sector. China Automotive Systems, Inc. (NASDAQ: CAAS), a titan of power steering development in China, has nailed it by meeting the ASPICE 4.0 Capability Level 2. That's a big one, folks. Verified by a partnership between a European automaker and UL, this achievement is no fluke....

Continue Reading
OMLYCLO Shakes Up U.S. Biologic Market as Key Player

Updated Category News Views 16

Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...

Continue Reading
#L.A. Rising Podcast: From Fires to International Fame

Updated Category News Views 18

From Ashes to Airwaves Gritty stories of survival often cut deeper than any wonky industry analysis or corporate earnings report. When you've been through the wringer and come out the other side, that experience sticks with you—and for Kim S. Marshall, it ignited something personal yet universal with the #L.A. Rising podcast. Emerging from the 2025 L.A. fires, this...

Continue Reading
Christmas Injury Lawyers Unveils SC Knowledge Center

Updated Category News Views 6

In the world of legal labyrinths, sometimes you just need a guiding light, especially following a car accident. That's where the freshly launched South Carolina Car Accident Law Knowledge Center steps in. It’s no magic wand, but Christmas Injury Lawyers are certainly trying to cut the chaos. This online hub covers more ground than a small library, boasting 40 guides...

Continue Reading
Travelers Turn to Direct Booking Amid Cost Surge

Updated Category News Views 20

Getting Ahead of the Travel Expense Game Rising fees and tighter budgets haven't persuaded holiday travelers to abandon their plans. Instead, they’re sharpening their axes, looking for clearer paths to their vacation goals without slicing off an arm and a leg. With the cost of travel climbing faster than a runaway elevator, folks are getting smart about where their...

Continue Reading
Dan Brown Joins Guidewire: Big Moves in P&C Software

Updated Category News Views 17

Turning the Insurance World on Its Head Just when you think the enterprise software scene is getting predictable, along comes a bit of news to shake things up. Guidewire, a name known in the P&C insurance software world, has roped in a veteran—Dan Brown—who's got more than a quarter-century under his belt shaping product strategies. It’s not just another suit...

Continue Reading
Event Industry Power 50 Voting Surge Ahead of Close

Updated Category News Views 15

An Unexpected Wave of Enthusiasm in Event Industry The Event Industry Power 50 is getting some serious action this year. Over 3,500 votes have already rolled in, smashing last year's numbers with days still left on the clock. It seems like folks can't wait to see their favorite event powerhouses crowned at this year's gala, which kicks off October 27 in New York City....

Continue Reading
ProClad Unveils Innovative Hybrid 2.0 Cookware

Updated Category News Views 15

Revolutionizing Cookware: The Launch of Hybrid 2.0 Today, everyone's buzzing about ProClad's big reveal—the Hybrid 2.0 Pan. Now, before you roll those skeptical eyes, hear me out. This isn’t your average bit of kitchen fluff; it’s a heavyweight contender stepping into the everyday cooking ring. What they've done here is combine the muscle of stainless steel searing...

Continue Reading
TRIMAX Poised to Meet AI-Driven Power Challenges

Updated Category News Views 13

TRIMAX's Bold Move into AI-Powered Infrastructure It feels like we're standing on the cusp of a seismic shift, folks. Artificial intelligence isn't just another buzzword anymore—it's a juggernaut reshaping our digital world. TRIMAX Power Systems is gearing up to ride this wave, with its eyes set on capturing a chunk of the booming demand for fast-deployable power...

Continue Reading
Palm Beach Royals Boost Pickleball's Popularity Surge

Updated Category News Views 23

A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...

Continue Reading

Top 5 Most Recently Viewed Articles

Ascletis Kicks Off Phase III Trials for Oral GLP-1 Drug

Updated Category News Views 68

Dose One: A Step Closer to an Oral Obesity Treatment August 30, 2026, marks a pivotal moment for Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") as they announce the first patient dosed in their global phase III clinical trial of ASC30. This little pill might pack a punch, tackling obesity—a beast of a challenge that's battering waistlines globally. So what's the big deal...

Continue Reading
Biodesix and APAPP Team Up for Innovative Lung Cancer Education

Updated Category News Views 128

Collaboration to Enhance Lung Cancer Care Biodesix, Inc. (Nasdaq: BDSX), a prominent name in the diagnostic solutions sector, has announced an exciting new partnership with the Association of Pulmonary Advanced Practice Providers (APAPP). This collaboration aims to roll out comprehensive educational programs designed specifically for Advanced Practice Providers (APPs),...

Continue Reading
Westinghouse's New Contract Propels AP1000 Reactor Feasibility

Updated Category News Views 219

Westinghouse's Strategic Contract with GEN energija Westinghouse Electric Company announced an exciting partnership with Slovenia’s state-owned power firm GEN energija. The duo aims to conduct a comprehensive Technical Feasibility Study (TFS) focused on the deployment of the AP1000 reactor, a pivotal part of Slovenia's nuclear new-build strategy. Collaborating alongside...

Continue Reading
AbbVie Enhances Psychiatry Pipeline with Gilgamesh Acquisition

Updated Category News Views 199

AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin AbbVie (NYSE: ABBV) has successfully finalized its acquisition of Gilgamesh Pharmaceuticals' lead investigational compound, bretisilocin. This strategic acquisition strengthens AbbVie's commitment to pioneering innovations in psychiatric treatments. Expanding the Psychiatry Pipeline The acquisition of...

Continue Reading
Automotive Wiring Harness Market Poised for Growth

Updated Category News Views 8

Market Projections and Growth Trajectory Roll up your sleeves, folks, because the automotive wiring harness market is gearing up for some shifts. Aiming to expand from $42.95 billion in 2026 to a robust $49.29 billion by 2033, the projected CAGR clocks in at a humble 2%, but don’t be fooled—there’s more beneath the surface here that’s worth a seasoned glance. BEV...

Continue Reading